ASCO 2019

#ASCO19: Sanofi sets the stage for a late arrival of their multiple myeloma drug isatuximab — with J&J and Genmab laying in wait
Endpoints
Sun, 06/2/19 - 01:18 pm
Sanofi
Multiple Myeloma
isatuximab
ASCO 2019
ASCO: Pfizer, Astellas' Xtandi racks up more data for new prostate cancer approval
Fierce Pharma
Sun, 06/2/19 - 01:17 pm
Pfizer
Astellas
Xtandi
prostate cancer
ASCO 2019
Complete response rate in Nektar melanoma trial hits 34%
Fierce Biotech
Sun, 06/2/19 - 01:12 pm
Nektar
NKTR-214
Opdivo
ASCO 2019
melanoma
ASCO 2019 day three
Pharmaforum
Sun, 06/2/19 - 01:09 pm
ASCO 2019
Merck
AstraZeneca
pancreatic cancer
Novartis
alpelisib
Roche
entrectinib
ASCO 2019 day two
Pharmaforum
Sun, 06/2/19 - 01:01 pm
Gilead Sciences
Kite Pharma
KTE-X19
CAR-T
ASCO 2019
Novartis
Merck
Keytruda
spartalizumab
ASCO: Novartis' Kisqali posts first-in-class survival win in younger women
Fierce Pharma
Sat, 06/1/19 - 12:45 pm
breast cancer
ASCO 2019
Novartis
clinical trials
Kisqali
AZ/Merck & Co reveal data supporting PARP drug in prostate cancer
Pharmaforum
Sat, 06/1/19 - 12:43 pm
ASCO 2019
AstraZeneca
Merck
prostate cancer
olaparib
For some lung cancer patients, Keytruda provides lasting benefit
Biopharma Dive
Sat, 06/1/19 - 12:41 pm
Merck
Keytruda
ASCO 2019
lung cancer
Turning Point sinks on ASCO update for repotrectinib
BioCentury
Fri, 05/31/19 - 11:59 pm
ASCO 2019
Turning Point Therapeutics
repotrectinib
non-small cell lung cancer
ASCO 2019 day one
Pharmaforum
Fri, 05/31/19 - 11:46 am
ASCO 2019
JNJ
Erleada
AstraZeneca
Merck
Lynparza
prostate cancer
ASCO 2019 preview: Big Pharmas looking for cancer R&D revival as we hit next-gen crossroads
Fierce Biotech
Fri, 05/31/19 - 10:36 am
ASCO 2019
R&D
cancer
oncology
Grail, a deep-pocketed startup, outlines its plans for a blood test to detect cancer
Stat
Fri, 05/31/19 - 09:48 am
Grail
diagnostics
ASCO 2019
cancer
On the pulse of ASCO: pricing and clinical trial access
Pharmaforum
Thu, 05/30/19 - 09:37 am
ASCO 2019
clinical trial access
clinical trials
oncology
drug pricing
ASCO 2019 Preview: Presentations to Keep An Eye On
BioSpace
Thu, 05/30/19 - 09:35 am
ASCO 2019
Novartis
Oncoceutics
OncoNano Medicine
AstraZeneca
5 novel immuno-oncology targets to know before ASCO
Biopharma Dive
Thu, 05/23/19 - 10:54 pm
immuno-oncology
ASCO 2019
STING
LAG-3
TIM-3
TGF-Beta
OX40
Breast cancer survival data buoys Macrogenics and Puma
Biopharma Dive
Thu, 05/16/19 - 11:28 pm
Macrogenics
margetuximab
Puma Biotechnology
Nerlynx
breast cancer
ASCO 2019
FDA to launch program to facilitate expanded access at ASCO meeting
BioCentury
Thu, 05/16/19 - 11:27 pm
FDA
ASCO 2019
expanded access programs
compassionate use guidelines

Pages